BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22258288)

  • 1. Advising potential recipients on the use of organs from donors with primary central nervous system tumors.
    Warrens AN; Birch R; Collett D; Daraktchiev M; Dark JH; Galea G; Gronow K; Neuberger J; Hilton D; Whittle IR; Watson CJ;
    Transplantation; 2012 Feb; 93(4):348-53. PubMed ID: 22258288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated risk of cancer transmission from organ donor to graft recipient in a national transplantation registry.
    Desai R; Collett D; Watson CJ; Johnson P; Evans T; Neuberger J
    Br J Surg; 2014 Jun; 101(7):768-74. PubMed ID: 24771410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of tumor transmission after thoracic allograft transplantation from adult donors with central nervous system neoplasm-A UNOS database study.
    Hynes CF; Ramakrishnan K; Alfares FA; Endicott KM; Hammond-Jack K; Zurakowski D; Jonas RA; Nath DS
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28135779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients: A Potential Cost-Effective Approach to Save Lives?
    Trotter PB; Summers DM; Ushiro-Lumb I; Robb M; Bradley JA; Powell J; Watson CJE; Neuberger J
    Transplantation; 2018 Apr; 102(4):664-672. PubMed ID: 29166338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system tumors in donors: misdiagnosis carries a high morbidity and mortality.
    Buell JF; Gross T; Alloway RR; Trofe J; Woodle ES
    Transplant Proc; 2005 Mar; 37(2):583-4. PubMed ID: 15848464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission of donor cancer into cardiothoracic transplant recipients.
    Buell JF; Trofe J; Hanaway MJ; Lo A; Rosengard B; Rilo H; Alloway R; Beebe T; First MR; Woodle ES
    Surgery; 2001 Oct; 130(4):660-6; discussion 666-8. PubMed ID: 11602897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and application of donors with primary central nervous system tumors.
    Wu JH; Qiao PF; Sun XY; Dong JH; Liao JX; Liu XY; Gao Z; Lan LG; Li HB; Su QD
    Clin Transplant; 2019 Oct; 33(10):e13677. PubMed ID: 31342552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver grafts from donors with central nervous system tumors: a single-center perspective.
    Kashyap R; Ryan C; Sharma R; Maloo MK; Safadjou S; Graham M; Tretheway D; Jain A; Orloff M
    Liver Transpl; 2009 Oct; 15(10):1204-8. PubMed ID: 19790151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ donors with primary central nervous system tumor.
    Detry O; Honoré P; Hans MF; Delbouille MH; Jacquet N; Meurisse M
    Transplantation; 2000 Jul; 70(1):244-8; discussion 251-2. PubMed ID: 10919616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donors with central nervous system malignancies: are they truly safe?
    Buell JF; Trofe J; Sethuraman G; Hanaway MJ; Beebe TM; Gross TG; Alloway R; First MR; Woodle ES
    Transplantation; 2003 Jul; 76(2):340-3. PubMed ID: 12883189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical overview of the current status of organ donors with primary central nervous system tumors.
    Hałoń A; Patrzałek D; Rabczyński J
    Ann Transplant; 2002; 7(1):6-14. PubMed ID: 12221906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of other organs recovered during in situ split-liver procurements.
    Ramcharan T; Glessing B; Lake JR; Payne WD; Humar A
    Liver Transpl; 2001 Oct; 7(10):853-7. PubMed ID: 11679982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplant tumor registry: donors with central nervous system tumors1.
    Kauffman HM; McBride MA; Cherikh WS; Spain PC; Delmonico FL
    Transplantation; 2002 Feb; 73(4):579-82. PubMed ID: 11889434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recently Published Literature as a Positive Influence on Selective Recipient Guided Use of So-Called Contraindicated Liver Donor Offers.
    Perera MT; Mirza DF
    Exp Clin Transplant; 2015 Oct; 13(5):490-2. PubMed ID: 26450472
    [No Abstract]   [Full Text] [Related]  

  • 16. First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer.
    Kauffman HM; McBride MA; Delmonico FL
    Transplantation; 2000 Dec; 70(12):1747-51. PubMed ID: 11152107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient and graft outcomes from deceased kidney donors age 70 years and older: an analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing database.
    Chavalitdhamrong D; Gill J; Takemoto S; Madhira BR; Cho YW; Shah T; Bunnapradist S
    Transplantation; 2008 Jun; 85(11):1573-9. PubMed ID: 18551062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the donor pool: use of marginal donors for solid organ transplantation.
    Alexander JW; Zola JC
    Clin Transplant; 1996 Feb; 10(1 Pt 1):1-19. PubMed ID: 8652891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age is an important predictor of kidney transplantation outcome.
    Veroux M; Grosso G; Corona D; Mistretta A; Giaquinta A; Giuffrida G; Sinagra N; Veroux P
    Nephrol Dial Transplant; 2012 Apr; 27(4):1663-71. PubMed ID: 21926404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ donors with exceptional medical conditions also count!
    Frutos MA; Mansilla JJ; Ruiz P; Lebrón M; Daga D; Guerrero F; Ortuño D; Carballo M; Parra D; Vázquez A
    Transplant Proc; 2008 Nov; 40(9):2874-6. PubMed ID: 19010132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.